Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier (Imiquimod) in genital warts

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1869-1873

  Arany, I ^a   Tyring, S K ^a   Brysk, M M ^a   Stanley, M A ^b,c   Tomai, M A ^d   Miller, R L ^d   Smith, M H ^d   McDermott, D J ^d   Slade, H B ^d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; INTERFERON; MESSENGER RNA; PROTEIN INHIBITOR; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONDYLOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSIVE ELEMENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SKIN BIOPSY; TREATMENT OUTCOME; VIRAL GENETICS; VIRUS GENE;

AMINOQUINOLINES; BIOPSY; CELL DIFFERENTIATION; CONDYLOMATA ACUMINATA; DNA-BINDING PROTEINS; DOUBLE-BLIND METHOD; GENE EXPRESSION REGULATION; HUMANS; INTERFERON INDUCERS; INTERFERONS; KERATINOCYTES; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEINS; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0033933610     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1869-1873.2000     Document Type: Article

References (39)

1. Anonymous. 1997. Imiquimod for genital warts. Med. Lett. Drugs Ther. 39:118-119.
2. Arany, I., M. M. Brysk, H. Brysk, and S. K. Tyring. 1996. Response to interferon treatment decreases with epidermal dedifferentiation in condylomas. Antivir. Res. 32:19-26.
3. Arany, I., and S. K. Tyring. 1996. Activation of local cell-mediated immunity in interferon responsive patients with human papillomavirus-associated lesions. J. Interferon Cytokine Res. 16:453-460.
4. Arany, I., and S. K. Tyring. 1996. Status of local cellular immunity in interferon responsive and nonresponsive human papillomavirus-associated lesions. Sex. Transm. Dis. 26:475-480.
5. Beutner, K. R., S. L. Spruance, A. J. Hougham, T. L. Fox, M. L. Owens, and J. M. Douglas, Jr. 1998. Treatment of genital warts with an immune-response modifier (imiquimod). J. Am. Acad. Dermatol. 38:230-239.
6. Bottrel, R. L. A., Y.-L. Yang, D. E. Levy, M. Tomai, and L. F. L. Reis. 1999. The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6. Antimicrob. Agents Chemother. 43:856-861.
7. Brysk, M. M., I. Arany, H. Brysk, S.-H. Chen, K. H. Calhoun, and S. K. Tyring. 1995. Epithelial cell responsiveness to interferon gamma: epidermis vs. buccal mucosa. Mol. Cell. Differ. 3:213-223.
8. Brysk, M. M., I. Arany, H. Brysk, S.-H. Chen, K. H. Calhoun, and S. K. Tyring. 1995. Gene expression of markers associated with proliferation and differentiation in keratinocytes cultured from skin and from oral mucosa. Arch. Oral Biol. 40:855-862.
9. Darnell, J. E. 1997. STATs and gene regulation. Science 277:1630-1635.
10. Edwards, L., A. Ferenczy, L. Eron, D. Baker, M. L. Owens, T. L. Fox, A. J. Hougham, and K. A. Schmitt. 1998. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch. Dermatol. 134:25-30.
11. Garcia, R., and R. Jove. 1998. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5:79-85.
12. Gibson, S. J., L. M. Imbertson, T. L. Wagner, T. L. Testerman, M. J. Reiter, R. L. Miller, and M. A. Tomai. 1995. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J. Interferon Cytokine Res. 15:537-545.
13. Gross, G. 1997. Therapy of human papillomavirus infection and associated epithelial tumors. Intervirology 40:368-377.
14. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducihle genes. Cell 58:729-739.
15. Harada, H., E.-I. Takahashi, S. Itoh, K. Harada, T.-A. Hori, and T. Taniguchi. 1994. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14:1500-1509.
16. Harada, H., T. Taniguchi, and N. Tanaka. 1998. The role of interferon regulatory factors in the interferon system and cell growth. Biochimie 80: 641-650.
17. Hennings, H., D. Michael, C. Cheng, P. Steinert, K. Holbrook, and S. H. Yuspa. 1980. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254.
18. Hobart, M., V. Ramassar, N. Goes, J. Urmson, and P. F. Halloran. 1917. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:4260-4269.
19. Hochhaus, A., X. Yan, A. Willer, R. Hehlmann, M. Y. Gordon, J. M. Goldman, and J. V. Melo. 1997. Expression of interferon regulatory factor (IRF) genes and response to interferon-α in chronic myeloid leukemia. Leukemia 11:933-939.
20. Hoey, T., and U. Schindler. 1998. STAT structure and function in signaling. Curr. Opin. Genet. Dev. 8:582-587.
21. Horvath, C. M., and J. E. Darnell. 1997. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9:233-239.
22. Kiuchi, N., K. Nakajima, M. Ichiba, T. Fukada, M. Narimatsu, K. Mizuno, M. Hibi, and T. Hirano. 1999. STAT3 is required for the gp130-mediated full activation of the c-myc genes. J. Exp. Med. 189:63-73.
23. Kono, T., S. Kondo, S. Pasture, G. M. Shivji, M. A. Tomai, R. C. McKenzie, and D. N. Sauder. 1994. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res. 13:71-76.
24. Lamb, P., H. M. Seidel, J. Haslam, L. Milocco, L. V. Kessler, R. B. Stein, and J. Rosen. 1995. STAT protein complexes activated by interferon-γ and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucleic Acids Res. 23:3283-3289.
25. Leaman, D. W., S. Leung, X. Li, and G. R. Stark. 1996. Regulation of STAT-dependert pathways by growth factors and cytokines. FASEB J. 10: 1578-1588.
26. Liu, B., J. Liao, X. Rao, S. A. Kushner, C. D. Chung, and D. D. Chang. 1998. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95:10626-10631.
27. Luger, T. A., and T. Schwarz. 1990. Evidence for an epidermal cytokine network. J. Investig. Dermatol. 95:100S-104S.
28. Matsue, H., P. D. Cruz, Jr., P. R. Bergstresser, and A. Takashima. 1992. Cytokine expression by epidermal cell subpopulations. J. Investig. Dermatol. 99:42S-45S.
29. Memar, O., I. Arany, and S. K. Tyring. 1995. Skin associated lymphoid tissue in HIV-1, HPV and HSV infections. J. Investig. Dermatol. 105:99S-104S.
30. Miller, R. L., J. F. Gerster, M. L. Owens, H. B. Slade, and M. A. Tomai. 1999. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int. J. Immunopharmacol. 21:1-14.
31. Nguyen, H., J. Hiscott, and P. M. Pitha. 1997. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8:293-320.
32. Stancato, L. F., M. David, C. Carter-Su, A. C. Larner, and W. B. Pratt. 1996. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J. Biol. Chem. 271:4134-4137.
33. Stanley, M. A. 1999. Mechanism of action of imiquimod. Papillomavirus Rep. 10:23-29.
34. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
35. Starr, R., and D. J. Hilton. 1999. Negative regulation of the JAK/STAT pathway. Bioessays 21:47-52.
36. Taniguchi, T., N. Tanaka, and S. Taki. 1998. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1. Eur. Cytokine Netw. 9:43-18.
37. Testerman, T. L., J. F. Gerster, L. M. Imbertson, M. J. Reiter, R. L. Miller, S. J. Gibson, T. L. Wagner, and M. A. Tomai. 1995. Cytokine induction by the immunomodulators imiquimod and S-27609. J. Leukoc. Biol. 58:365-372.
38. Tyring, S. K., I. Arany, M. A. Stanley, M. A. Tomai, R. L. Miller, M. H. Smith, D. J. McDermott, and H. B. Slade. 1998. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J. Infect. Dis. 178:551-555.
39. Wehinger, J., F. Gouilleux, B. Groner, J. Finke, R. Mertelsmann, and R. M. Weber-Nordt. 1996. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394:365-370.